Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Medrxiv : the Preprint Server for Health Sciences|July 30, 2026
Multi-omic Profiling of Recurrence Risk Across Breast Cancer SubtypesA Eden Cruikshank, Pooja Chandra, Christopher I Li, et al.BMC Medical Genomics|February 2, 2019
Integration of genomic copy number variations and chemotherapy-response biomarkers in pediatric sarcomaLijun Cheng, Pankita H Pandya, Enze Liu, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 22, 2025
Longitudinal Genomic Analysis of Five Cases of Recurrent ThymomasYongfeng He, Peter Waltman, Troy Kane, et al.International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|September 6, 2021
Molecular Evaluation of Low-grade Low-stage Endometrial Cancer With and Without RecurrenceCathleen E Matrai, Kentaro Ohara, Kenneth Wha Eng, et al.Molecular Oncology|March 1, 2022
The genomic landscape of metastatic clear cell renal cell carcinoma after systemic therapyJohannes C van der Mijn, Kenneth W Eng, Pooja Chandra, et al.Blood Advances|December 1, 2022
Paired bone marrow and peripheral blood samples demonstrate lack of widespread dissemination of some CH clonesAfaf E G Osman, Nuria Mencia-Trinchant, Caner Saygin, et al.NPJ Precision Oncology|April 28, 2026
Multi-modal circulating cell-free DNA profiling to predict response to docetaxel in metastatic castration-resistant prostate cancerDavid D Chen, Anat Zimmer, David D Yang, et al.Cell Reports Methods|May 14, 2026
Tumor immune microenvironment reconstitution in patient-derived organoids enables therapy modeling for NSCLCEnrique Podaza, Jared Capuano, Hui-Hsuan Kuo, et al.Biorxiv : the Preprint Server for Biology|February 23, 2026
Deep learning-based non-invasive profiling of tumor transcriptomes from cell-free DNA for precision oncologyRobert D Patton, Alexander Netzley, Thomas W Persse, et al.NPJ Precision Oncology|April 21, 2026
EXaCT-2: an augmented and customizable oncology-focused whole exome sequencing platformPeter Waltman, Pooja Chandra, Ken W Eng, et al.Pageof 2